chlorambucil has been researched along with Acute Disease in 44 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
Acute Disease: Disease having a short and relatively severe course.
Excerpt | Relevance | Reference |
---|---|---|
"Sixty-seven patients with acute nonlymphoblastic leukemia (ANLL) and above the age of 60 years were randomly allocated to treatment with either prednimustine + vincristine or cycles with cytosine arabinoside and thioguanine." | 9.05 | Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia. ( Andersson, B; Björkholm, M; Engstedt, L; Gahrton, G; Hast, R; Holm, G; Killander, A; Lantz, B; Lockner, D; Lönnqvist, B; Mellstedt, H; Oberg, G; Palmblad, J; Paul, C; Peterson, C; Simonsson, B; Stalfelt, AM; Udén, AM; Wadman, B, 1982) |
"In polycythemia vera (PV), treatment with chlorambucil and radioactive phosphorus (p32) increases the risk of leukemic transformation from 1% to 13-14%." | 7.69 | Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. ( Fisher, SG; Godwin, J; Nand, S; Stock, W, 1996) |
"Chlorambucil is useful in patients with rheumatoid arthritis (RA) refractory to other agents but there is concern about the risk of haematological malignancy with this agent." | 7.67 | The oncogenicity of chlorambucil in rheumatoid arthritis. ( Browne, CD; Champion, GD; Cohen, ML; Day, RO; Graham, S; Patapanian, H; Sambrook, PN, 1988) |
"Prednimustine, an ester of chlorambucil and prednisolone, was evaluated for efficacy and toxicity in a selected group of leukemia patients with a poor prognosis." | 7.66 | A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts. ( Carter, SK; Gandara, DR; George, CB; Koretz, MM; Lewis, JP; Ries, CA; Schiff, SA, 1982) |
"The results of a five-year study of chlorambucil in patients suffering from rheumatoid arthritis are presented." | 7.65 | Rheumatoid arthritis treated with chlorambucil: a five-year follow-up. ( Thorpe, P, 1976) |
"In studies to determine the optimal treatment for polycythemia vera, 431 previously untreated patients whose disease met established diagnostic criteria were entered into a prospective, randomized controlled trial between 1967 and 1974." | 6.65 | Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. ( Berk, PD; Donovan, PB; Ellis, JT; Goldberg, JD; Landaw, SA; Laszlo, J; Najean, Y; Pisciotta, AV; Silverstein, MN; Wasserman, LR; Weinfeld, A, 1981) |
"Sixty-seven patients with acute nonlymphoblastic leukemia (ANLL) and above the age of 60 years were randomly allocated to treatment with either prednimustine + vincristine or cycles with cytosine arabinoside and thioguanine." | 5.05 | Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia. ( Andersson, B; Björkholm, M; Engstedt, L; Gahrton, G; Hast, R; Holm, G; Killander, A; Lantz, B; Lockner, D; Lönnqvist, B; Mellstedt, H; Oberg, G; Palmblad, J; Paul, C; Peterson, C; Simonsson, B; Stalfelt, AM; Udén, AM; Wadman, B, 1982) |
" malariae infection that acutely reactivated after 45 y of latency following treatment with chlorambucil and methylprednisolone is reported." | 3.70 | Drug-induced acute malaria. ( Bassaris, H; Skoutelis, A; Symeonidis, A; Vassalou, E, 2000) |
"In polycythemia vera (PV), treatment with chlorambucil and radioactive phosphorus (p32) increases the risk of leukemic transformation from 1% to 13-14%." | 3.69 | Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. ( Fisher, SG; Godwin, J; Nand, S; Stock, W, 1996) |
" Although multi-drug therapy is known to produce myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) in patients with CTD, treatment with single-agent therapy, particularly methotrexate, has rarely been associated with secondary MDS or AML." | 3.69 | Myelodysplastic syndromes and acute myeloid leukemia in connective tissue disease after single-agent chemotherapy. ( Farhi, DC; Rosenthal, NS, 1996) |
"Chlorambucil is useful in patients with rheumatoid arthritis (RA) refractory to other agents but there is concern about the risk of haematological malignancy with this agent." | 3.67 | The oncogenicity of chlorambucil in rheumatoid arthritis. ( Browne, CD; Champion, GD; Cohen, ML; Day, RO; Graham, S; Patapanian, H; Sambrook, PN, 1988) |
"Prednimustine, an ester of chlorambucil and prednisolone, was evaluated for efficacy and toxicity in a selected group of leukemia patients with a poor prognosis." | 3.66 | A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts. ( Carter, SK; Gandara, DR; George, CB; Koretz, MM; Lewis, JP; Ries, CA; Schiff, SA, 1982) |
"The results of a five-year study of chlorambucil in patients suffering from rheumatoid arthritis are presented." | 3.65 | Rheumatoid arthritis treated with chlorambucil: a five-year follow-up. ( Thorpe, P, 1976) |
"Two cases of advanced ovarian carcinoma treated with chlorambucil and terminating in acute leukemia are presented and the literature reviewed." | 3.65 | Acute leukemia in advanced ovarian carcinoma after treatment with alkylating agents. ( Jafari, K; Lash, AF; Sotrel, G; Stepto, RC, 1976) |
"Patients with chronic lymphocytic leukemia (CLL) may have disease transformation to non-Hodgkin's lymphoma or prolymphocytic leukemia; however, development of therapy-related acute myeloid leukemia (t-AML) is unusual." | 2.70 | Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. ( Appelbaum, FR; Elias, L; Hines, JD; Kolitz, JE; Larson, RA; Morrison, VA; Peterson, BL; Rai, KR; Schiffer, CA; Shepherd, L, 2002) |
"We evaluated the occurrence of acute nonlymphocytic leukemia (ANL) among 1399 women with ovarian cancer who were treated in five randomized clinical trials." | 2.65 | Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials. ( Blessing, JA; Boice, JD; Dembo, AJ; Greene, MH; Greer, BE, 1982) |
"In studies to determine the optimal treatment for polycythemia vera, 431 previously untreated patients whose disease met established diagnostic criteria were entered into a prospective, randomized controlled trial between 1967 and 1974." | 2.65 | Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. ( Berk, PD; Donovan, PB; Ellis, JT; Goldberg, JD; Landaw, SA; Laszlo, J; Najean, Y; Pisciotta, AV; Silverstein, MN; Wasserman, LR; Weinfeld, A, 1981) |
"acute lymphoblastic leukemia-type chemotherapy that incorporated high-dose cytarabine was effective in achieving an minimal residual disease-negativity rate of 69% in evaluated patients, which was also predictive of better outcome." | 1.56 | Clinicoepidemiologic Profile and Outcome Predicted by Minimal Residual Disease in Children With Mixed-phenotype Acute Leukemia Treated on a Modified MCP-841 Protocol at a Tertiary Cancer Institute in India. ( Banavali, S; Gujral, S; Myint, HH; Narula, G; Patkar, N; Prasad, M; Subramanian, P; Tandon, S; Tembhare, P, 2020) |
"Hodgkin's disease is curable in the majority of patients, although a proportion of patients are resistant to or relapse after initial therapy." | 1.30 | High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. ( Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D, 1999) |
"Of 602 patients treated for non-Hodgkin's lymphomas, 9 developed overt acute nonlymphocytic leukemia or preleukemia with refractory cytopenia and cytogenetic abnormalities of the bone marrow." | 1.27 | Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents. ( Ersbøll, J; Keiding, N; Larsen, MS; Larsen, SO; Nissen, NI; Pedersen-Bjergaard, J; Philip, P; Schultz, H; Sørensen, HM, 1985) |
"Thirteen cases of acute nonlymphocytic leukemia occurred among 5455 patients, as compared to 0." | 1.26 | Acute leukemia after alkylating-agent therapy of ovarian cancer. ( Fraumeni, JF; Hoover, R; Reimer, RR; Young, RC, 1977) |
" Although hematologic malignancies have been known to develop consequent to long-term use of alkylating agents, and bone marrow suppression is well known, acute myelofibrosis has not, to our knowledge, been reported as a complication of this therapy, nor has any specific myeloproliferative syndrome been described consequent to such therapy in a patient with PSS." | 1.26 | Acute myelofibrosis in progressive systemic sclerosis. Report of a case developing during long term chlorambucil therapy and discussion of pathogenetic factors. ( Chung, KB; Gisser, SD, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (61.36) | 18.7374 |
1990's | 8 (18.18) | 18.2507 |
2000's | 8 (18.18) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (2.27) | 2.80 |
Authors | Studies |
---|---|
Myint, HH | 1 |
Tandon, S | 1 |
Narula, G | 1 |
Prasad, M | 1 |
Subramanian, P | 1 |
Patkar, N | 1 |
Tembhare, P | 1 |
Gujral, S | 1 |
Banavali, S | 1 |
Mahajan, A | 1 |
Nirmal, S | 1 |
English, MW | 1 |
Jenney, ME | 1 |
Lazda, ED | 1 |
Morrison, VA | 1 |
Rai, KR | 1 |
Peterson, BL | 1 |
Kolitz, JE | 1 |
Elias, L | 1 |
Appelbaum, FR | 1 |
Hines, JD | 1 |
Shepherd, L | 1 |
Larson, RA | 1 |
Schiffer, CA | 1 |
Metayer, C | 1 |
Curtis, RE | 1 |
Vose, J | 1 |
Sobocinski, KA | 1 |
Horowitz, MM | 1 |
Bhatia, S | 1 |
Fay, JW | 1 |
Freytes, CO | 1 |
Goldstein, SC | 1 |
Herzig, RH | 1 |
Keating, A | 1 |
Miller, CB | 1 |
Nevill, TJ | 1 |
Pecora, AL | 1 |
Rizzo, JD | 1 |
Williams, SF | 1 |
Li, CY | 1 |
Travis, LB | 1 |
Weisdorf, DJ | 1 |
Yen, CJ | 1 |
Huang, WT | 1 |
Huang, JJ | 1 |
Chen, FF | 1 |
Sung, JM | 1 |
Balakrishnan, C | 1 |
Pathan, E | 1 |
Khodaiji, S | 1 |
Dasgupta, A | 1 |
Mangat, G | 1 |
Joshi, VR | 1 |
Shanks, RH | 1 |
Rizzieri, DA | 1 |
Flowers, JL | 1 |
Colvin, OM | 1 |
Adams, DJ | 1 |
Greene, MH | 1 |
Boice, JD | 1 |
Greer, BE | 1 |
Blessing, JA | 1 |
Dembo, AJ | 1 |
Ayulo, MA | 1 |
Preisler, HD | 1 |
Berk, PD | 2 |
Goldberg, JD | 2 |
Silverstein, MN | 1 |
Weinfeld, A | 1 |
Donovan, PB | 2 |
Ellis, JT | 2 |
Landaw, SA | 2 |
Laszlo, J | 1 |
Najean, Y | 1 |
Pisciotta, AV | 1 |
Wasserman, LR | 3 |
Gandara, DR | 1 |
Ries, CA | 1 |
Schiff, SA | 1 |
George, CB | 1 |
Lewis, JP | 1 |
Koretz, MM | 1 |
Carter, SK | 1 |
Lönnqvist, B | 1 |
Andersson, B | 1 |
Björkholm, M | 1 |
Engstedt, L | 1 |
Gahrton, G | 1 |
Hast, R | 1 |
Holm, G | 1 |
Killander, A | 1 |
Lantz, B | 1 |
Lockner, D | 1 |
Mellstedt, H | 1 |
Palmblad, J | 1 |
Paul, C | 1 |
Peterson, C | 1 |
Simonsson, B | 1 |
Stalfelt, AM | 1 |
Udén, AM | 1 |
Wadman, B | 1 |
Oberg, G | 1 |
Fitzgerald, RH | 1 |
Wallace, KM | 1 |
Baker, AS | 1 |
Najman, A | 1 |
Gorin, NC | 1 |
Duhamel, G | 1 |
Roger, M | 1 |
Dry, J | 1 |
Ho, WK | 1 |
Robertson, MR | 1 |
Macdonald, GJ | 1 |
Charlesworth, JA | 1 |
Pussell, BA | 1 |
Nand, S | 1 |
Stock, W | 1 |
Godwin, J | 1 |
Fisher, SG | 1 |
Rosenthal, NS | 1 |
Farhi, DC | 1 |
Sánchez Fayos, J | 1 |
Román Barbero, A | 1 |
Nevado Reviriego, I | 1 |
Drake, WM | 1 |
Monson, JP | 1 |
Trainer, PJ | 1 |
Sharief, M | 1 |
Dick, JP | 1 |
Kelsey, SM | 1 |
Harrison, CN | 1 |
Gregory, W | 1 |
Hudson, GV | 1 |
Devereux, S | 1 |
Goldstone, AH | 1 |
Hancock, B | 1 |
Winfield, D | 1 |
MacMillan, AK | 1 |
Hoskin, P | 1 |
Newland, AC | 1 |
Milligan, D | 1 |
Linch, DC | 1 |
Skoutelis, A | 1 |
Symeonidis, A | 1 |
Vassalou, E | 1 |
Bassaris, H | 1 |
Pichon, N | 1 |
Debette-Gratien, M | 1 |
Cessot, F | 1 |
Paraf, F | 1 |
Labrousse, F | 1 |
Sautereau, D | 1 |
Pillegand, B | 1 |
Schütterle, G | 1 |
Goubeaud, G | 1 |
Hoffman, R | 1 |
Reimer, RR | 1 |
Hoover, R | 1 |
Fraumeni, JF | 1 |
Young, RC | 1 |
Gisser, SD | 1 |
Chung, KB | 1 |
Buriot, D | 1 |
Prieur, AM | 1 |
Lebranchu, Y | 1 |
Messerschmitt, J | 1 |
Griscelli, C | 1 |
Morrison, J | 1 |
Yon, JL | 1 |
Thorpe, P | 1 |
Andrejak, M | 1 |
Pocheville, M | 1 |
Giudicelli, CP | 1 |
Masbernard, A | 1 |
Sotrel, G | 1 |
Jafari, K | 1 |
Lash, AF | 1 |
Stepto, RC | 1 |
Brandis, M | 1 |
Krause, PH | 1 |
Hünermund, G | 1 |
Bahlmann, J | 1 |
Avilés, A | 1 |
Díaz-Maqueo, JC | 1 |
Ayala, JR | 1 |
Cortés, HD | 1 |
García, EL | 1 |
Cullis, JO | 1 |
Hyde, RD | 1 |
Patapanian, H | 1 |
Graham, S | 1 |
Sambrook, PN | 1 |
Browne, CD | 1 |
Champion, GD | 1 |
Cohen, ML | 1 |
Day, RO | 1 |
Fruchtman, SM | 1 |
Berlin, NI | 1 |
Peterson, P | 1 |
Geller, SA | 1 |
Rappaport, H | 1 |
Donham, JA | 1 |
Denning, V | 1 |
Pedersen-Bjergaard, J | 1 |
Ersbøll, J | 1 |
Sørensen, HM | 1 |
Keiding, N | 1 |
Larsen, SO | 1 |
Philip, P | 1 |
Larsen, MS | 1 |
Schultz, H | 1 |
Nissen, NI | 1 |
Laroche, C | 1 |
Caquet, R | 1 |
Remy, JM | 1 |
Faĭnshteĭn, FE | 1 |
Lagrue, G | 1 |
Bariety, J | 1 |
Druet, P | 1 |
Hirbec, G | 1 |
Manassero, J | 1 |
Vaillaud, JC | 1 |
Paglia, R | 1 |
Geneste, F | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Multicenter Phase 2 Study of Efficacy and Safety of Pegylated Interferon-alfa 2a in Polycythemia Vera Patients[NCT00241241] | Phase 2 | 40 participants | Interventional | 2004-09-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for chlorambucil and Acute Disease
Article | Year |
---|---|
[Efficacious treatment of a fatal blood disease: polycythemia vera].
Topics: Acute Disease; Alkylating Agents; Busulfan; Chlorambucil; Humans; Hydroxyurea; Leukemia, Myeloid; Le | 1997 |
Natural history and management of polycythemia vera.
Topics: Acute Disease; Adult; Antineoplastic Agents; Bloodletting; Cell Transformation, Neoplastic; Chloramb | 1979 |
[Clinical aspects of the problem of treating leukemias].
Topics: Acute Disease; Antineoplastic Agents; Chlorambucil; Chlorine; Chronic Disease; Daunorubicin; Dimetho | 1973 |
6 trials available for chlorambucil and Acute Disease
Article | Year |
---|---|
Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chlorambuci | 2002 |
Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials.
Topics: Acute Disease; Adult; Aged; Alkylating Agents; Animals; Chlorambucil; Clinical Trials as Topic; Fema | 1982 |
Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.
Topics: Acute Disease; Chlorambucil; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Leu | 1981 |
Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia.
Topics: Acute Disease; Aged; Blood Cell Count; Chlorambucil; Cytarabine; Drug Therapy, Combination; Female; | 1982 |
Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
Topics: Acute Disease; Age Factors; Bloodletting; Chlorambucil; Combined Modality Therapy; False Positive Re | 1986 |
Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.
Topics: Acute Disease; Aged; Bloodletting; Bone Marrow; Bone Marrow Cells; Chlorambucil; Combined Modality T | 1986 |
35 other studies available for chlorambucil and Acute Disease
Article | Year |
---|---|
Clinicoepidemiologic Profile and Outcome Predicted by Minimal Residual Disease in Children With Mixed-phenotype Acute Leukemia Treated on a Modified MCP-841 Protocol at a Tertiary Cancer Institute in India.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; | 2020 |
Acute tumor lysis syndrome in Hodgkin disease.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Chlorambucil; Hodgk | 2002 |
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemoth | 2003 |
Prolonged chlorambucil therapy for idiopathic membranous nephropathy may induce myelodysplastic syndrome and acute leukemia: report of a case.
Topics: Acute Disease; Adult; Antineoplastic Agents, Alkylating; Chlorambucil; Chromosomes, Human, Pair 7; F | 2004 |
Myelodysplasia and acute myeloid leukaemia in a case of rheumatoid arthritis with secondary amyloidosis treated with chlorambucil.
Topics: Acute Disease; Amyloidosis; Antirheumatic Agents; Arthritis, Rheumatoid; Chlorambucil; Fatal Outcome | 2004 |
Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemia.
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Camptothecin; Caspase 3; Caspase 7; Caspases; Cell | 2005 |
Prednimustine in acute nonlymphocytic leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Chlorambucil; Drug Evaluation; Female; Humans; Leukemia; Mal | 1983 |
A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts.
Topics: Acute Disease; Adult; Aged; Anemia, Aplastic; Chlorambucil; Drug Evaluation; Female; Humans; Leukemi | 1982 |
Acute obstructive uric acid nephropathy after treatment of neoplastic adenopathy.
Topics: Acute Disease; Chlorambucil; Constriction, Pathologic; Female; Humans; Kidney Diseases; Leukemia, Ly | 1981 |
[Acute myelofibrosis after chlorambucil treatment (author's transl)].
Topics: Acute Disease; Chlorambucil; Humans; Male; Middle Aged; Multiple Sclerosis; Primary Myelofibrosis | 1980 |
Association of acute leukaemia with chlorambucil after renal transplantation.
Topics: Acute Disease; Chlorambucil; Humans; Kidney Transplantation; Leukemia; Postoperative Complications | 1994 |
Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Topics: Acute Disease; Anemia, Refractory, with Excess of Blasts; Busulfan; Cell Transformation, Neoplastic; | 1996 |
Myelodysplastic syndromes and acute myeloid leukemia in connective tissue disease after single-agent chemotherapy.
Topics: Acute Disease; Adult; Aged; Antigens, CD; Antirheumatic Agents; Chlorambucil; Connective Tissue Dise | 1996 |
Acute polyneuropathy with chronic lymphocytic leukaemia and paraproteinaemia: response to chlorambucil and prednisolone.
Topics: Acute Disease; Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Chlorambucil; Demy | 1998 |
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; | 1999 |
Drug-induced acute malaria.
Topics: Acute Disease; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Chlorambucil; Female; Hu | 2000 |
[Acute cholestatic hepatitis due to chlorambucil].
Topics: Acute Disease; Aged; Antineoplastic Agents, Alkylating; Biopsy, Needle; Chemical and Drug Induced Li | 2001 |
[Possibilities and limitations of immunosuppressive therapy for glomerulonephritis].
Topics: Acute Disease; Antilymphocyte Serum; Azathioprine; Chlorambucil; Chronic Disease; Cyclophosphamide; | 1977 |
Acute leukemia after alkylating-agent therapy of ovarian cancer.
Topics: Acute Disease; Alkylating Agents; Altretamine; Chlorambucil; Cyclophosphamide; Female; Fluorouracil; | 1977 |
Acute myelofibrosis in progressive systemic sclerosis. Report of a case developing during long term chlorambucil therapy and discussion of pathogenetic factors.
Topics: Acute Disease; Adult; Bone Marrow; Cell Division; Chlorambucil; Female; Fibroblasts; Hematopoietic S | 1979 |
[Acute leukemia in 3 children with chronic juvenile arthritis treated with chlorambucil].
Topics: Acute Disease; Alkylating Agents; Arthritis, Juvenile; Child; Child, Preschool; Chlorambucil; Chromo | 1979 |
Acute leukemia following chlorambucil therapy of advanced ovarian and fallopian tube carcinoma.
Topics: Acute Disease; Carcinoma; Chlorambucil; Fallopian Tube Neoplasms; Female; Humans; Leukemia; Middle A | 1978 |
Rheumatoid arthritis treated with chlorambucil: a five-year follow-up.
Topics: Acute Disease; Aged; Arthritis, Rheumatoid; Chlorambucil; Chronic Disease; Female; Follow-Up Studies | 1976 |
[Iatrogenic acute colitis caused by sulfamethoxazole-trimethoprim].
Topics: Acute Disease; Adult; Chlorambucil; Colitis; Drug Combinations; Humans; Iatrogenic Disease; Male; Su | 1976 |
Acute leukemia in advanced ovarian carcinoma after treatment with alkylating agents.
Topics: Acute Disease; Adenocarcinoma, Papillary; Adult; Alkylating Agents; Chlorambucil; Cystadenoma; Femal | 1976 |
[Rapidly progressive glomerulonephritis in a child. Clinical and histological observation over 3 1/2 years (author's transl)].
Topics: Acute Disease; Anuria; Biopsy, Needle; Child; Chlorambucil; Glomerular Filtration Rate; Glomerulonep | 1976 |
Hodgkin's disease and acute leukemia. Is it a true association?
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil | 1992 |
Acute epiglottitis in immunocompromised patients--a report of two cases.
Topics: Acute Disease; Chlorambucil; Cyclophosphamide; Epiglottitis; Humans; Immunocompromised Host; Leukemi | 1991 |
The oncogenicity of chlorambucil in rheumatoid arthritis.
Topics: Acute Disease; Arthritis, Rheumatoid; Azathioprine; Carcinogens; Chlorambucil; Humans; Leukemia, Mye | 1988 |
Acute leukemia in polycythemia vera.
Topics: Acute Disease; Antigens, Neoplasm; Bloodletting; Chlorambucil; Chromosome Aberrations; Chromosome Di | 1986 |
Cold agglutinin syndrome: nursing management.
Topics: Acute Disease; Anemia, Hemolytic, Autoimmune; Blood Transfusion; Chlorambucil; Chronic Disease; Comb | 1985 |
Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
Topics: Acute Disease; Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Prot | 1985 |
[Acute erythroleukemia following treatment of malignant exophthalmos with chlorambucil].
Topics: Acute Disease; Aged; Chlorambucil; Female; Graves Disease; Humans; Leukemia, Erythroblastic, Acute; | 1972 |
[2 cases of apparently primary glomerulopathies with deposits. Recovery with immunodepressive agents. Secondary onset of an acute S.L.E. without renal involvement].
Topics: Acute Disease; Biopsy; Chlorambucil; Glomerulonephritis; Humans; Inclusion Bodies, Viral; Kidney Glo | 1972 |
[A case of acute glomerulonephritis supposed to be malignant. Complete clinical, biological and histological remission after a combined chlorambucil and indomethacin treatment].
Topics: Acute Disease; Child; Chlorambucil; Diagnosis, Differential; Female; Glomerulonephritis; Humans; Ind | 1970 |